Schedule a Meeting with a Catalent Expert at the 2023 Global Drug Bioavailability Enhancement Summit

Date: June 27-28, 2023
Location: Princeton, New Jersey

FEATURED SPEAKER

Ellie Au, Ph.D.
Group Lead, Product Development, Catalent

Session Title: Development Considerations for Lipid-Based Formulation (LBF) from Preclinical Toxicology to Clinical Studies
Session Date: Tuesday, June 27, 2023
Session Time: 11:35am – 12:15pm EDT
Abstract/Key Learning Objectives:

• • What determines an API as a good candidate for LBF?
  • How to leverage the advantages of LBF in early development to expedite candidate selection of poorly soluble drugs?
  • Why one shouldn’t rule out LBF in preclinical studies?
  • Key consideration in dosing lipid formulations to preclinical models and strategy to enable high-dose preclinical toxicology study.
  • How to successfully transition a preclinical LBF to a viable clinical dosage form?